| Home | ||||||||||||
| Vaccine Testing |
||||||||||||
Research Materials
|
||||||||||||
| Links | ||||||||||||
| Contacts | ||||||||||||
| Frequently Asked Questions | ||||||||||||
| Publications | ||||||||||||
Recombinant Proteins for Large Scale Studies
The production of recombinant proteins for routine use in laboratory studies is now enabled via ordering the recombinant clone for the antigen of interest. Detailed protocols and references are provided with orders so that laboratories can make proteins as needed without the delays of shipping and TBVTRM prioritization. The use of recombinant proteins for in vitro studies as part of a large clinical study or trial and for structural analysis demands a purification scale that is often incompatable with the resources of most academic institutions. Thus, recombinant proteins will be made available to laboratories involved in large scale clinical trials and structural studies. Principal investigators who wish to be considered must first register with the contract and have a fully executed MTA on file. These needs will then be addressed via submission of a detailed research plan and justification. All submissions will be considered, though there may be a significant delay based on the scope of project and prior proposals in queue. Additionally, all activities in this scope of work will be considered collaborations; thus there must be a guarantee of disclosure by all parties. Please contact Dr. Karen Dobos-Elder for additional information or to submit a research proposal.
Return to Recombinant Plasmids | Return to Materials Available